NEW YORK, Oct. 18 /PRNewswire/ -- On October 2, Paul Lisenby, Chairman and CEO of XTend Medical Corp. (Pink Sheets: XMDC) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:
-- focus on creating medical technologies for the diabetes market
-- demographic trends bolstering the company's growth prospects
-- management bios
-- how strategic partnerships play a role in the company's growth
-- reasons the company's solutions have a competitive edge
-- upcoming milestones for investors to watch for
To hear the interview in its entirety, and to read an in-depth report on the company, visit http://www.wallst.net/superstocks/superstocks_profile.asp?ticker=xmdc
On October 5, Jules Fisher, Chief Financial Officer for Possis Medical, Inc. (Nasdaq: POSS) (http://www.possis.com) updated the investment community in an all-new interview with http://www.wallst.net. Interview highlights include detailed discussions on the following topics:
-- how the company was able to offset the decline from its coronary
business
-- moving into a "recovery mode"
-- reasons the company is "behaving like a growth company again"
-- market opportunities for the company's medical technology solutions
-- upcoming milestones for investors to watch for
To hear the interview in its entirety, visit
| SOURCE WallStreet Direct, Inc. Copyright©2007 PR Newswire. All rights reserved |